Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics announces positive three-year EMBARK results for Elevidys, fueling optimism despite ongoing regulatory scrutiny. The stock sees a surge in social media attention following Elevidys' listing on Japan's NHI drug price list.
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. is a healthcare company focused on gene therapy for rare diseases.
Sarepta Therapeutics, Inc. uses the ticker $SRPT for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Sarepta Therapeutics, Inc. (SRPT) social dominance is up 336.12% from the previous week.
- Sarepta Therapeutics, Inc. (SRPT) posts created is up 61.96% from the previous month.
Price: $17.80
Price 24-Hour Time-Series Raw Data
The stock price has experienced a significant downturn due to missed Q4 Elevidys sales targets and regulatory headwinds. However, recent social media sentiment indicates expectations of a recovery fueled by anticipated data releases and positive sales reports, such as Elevidys being listed on Japan's NHI drug price list.
24-Hour: 1.31% 7-Day: -3.94% 30-Day: -15.81%
1-Year High: $108.40 on 2025-02-20
1-Year Low: $11.90 on 2025-07-25
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Sarepta Therapeutics, Inc. (SRPT) is currently AltRank #717 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +343
[--] Months: [---] +435
[--] Year: [---] +71
1-Year High: [-----] on 2025-03-16
1-Year Low: [--] on 2025-03-19
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] no change
1-Year High: [--] on 2025-10-02
1-Year Low: [--] on 2025-03-09
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [-------] -6.20%
[--] Month: [---------] +55%
[--] Months: [----------] -48%
[--] Year: [----------] +65%
1-Year High: [---------] on 2025-07-18
1-Year Low: [-----] on 2026-02-16
Engagements by network (24h): X: [-----] Reddit: [--] News: [--] TikTok: [--] YouTube: [---]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -16%
[--] Month: [-----] +48%
[--] Months: [------] -60%
[--] Year: [------] +326%
1-Year High: [-----] on 2025-07-18
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): X: [---] Reddit: [--] News: [--] TikTok: [--] YouTube: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Sarepta Therapeutics, Inc. (SRPT) in the last [--] hours which is down 32% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] -23%
[--] Month: [---] +44%
[--] Months: [-----] -73%
[--] Year: [------] +691%
1-Year High: [-----] on 2025-07-17
1-Year Low: [--] on 2025-02-17
The most influential creators that mention Sarepta Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @IroquoiInvest | [--] | [---] | [--] | [---] |
| @n_hatami | [--] | [---------] | [--] | [---] |
| @SU_pharma | [--] | [-----] | [--] | [---] |
| @yachmod | [--] | [---] | [--] | [---] |
| @TequilaVernetti | [--] | [--] | [--] | [---] |
| @commonsenseplay | [--] | [------] | [--] | [---] |
| @OptionsAlertsAi | [--] | [---] | [--] | [---] |
| @DAYTRAD33679642 | [--] | [--] | [--] | [---] |
| @thefrancefoundation | [--] | [-----] | [--] | [---] |
| @princeess_anna_ | [--] | [--] | [--] | [---] |
Sentiment: 63%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 63%
Daily Average: 71%
[--] Week: 47% -16%
[--] Month: 59% -4%
[--] Months: 59% -14%
[--] Year: 59% -19%
1-Year High: 97% on 2025-07-04
1-Year Low: 34% on 2025-05-07
Most Supportive Themes:
- Elevidys Potential: (55%) Analysts are optimistic about Sarepta Therapeutics' potential for gene therapy, particularly Elevidys, citing potential upside and long-term value.
Most Critical Themes:
- Regulatory Concerns: (10%) Concerns about regulatory issues and market volatility following two patient deaths linked to Sarepta's gene therapy.
Social Dominance: 0.013%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.013%
Daily Average: 0.074%
[--] Week: 0.099% +0.076%
[--] Month: 0.031% -0.0063%
[--] Months: 0.031% -0.053%
[--] Year: 0.031% -0.018%
1-Year High: 0.576% on 2025-07-18
1-Year Low: 0.014% on 2025-12-06
Market Dominance: 0.0021%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0021%
Daily Average: 0%
1-Year High: 0.232% on 2025-03-31
1-Year Low: 0.0015% on 2025-07-25
Market Cap: $1,850,541,722
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,850,541,722
Daily Average: $3,294,452,036
[--] Week: $1,850,541,722 -3.10%
[--] Month: $1,864,164,057 -16%
[--] Months: $1,864,164,057 -7.30%
[--] Year: $1,864,164,057 -84%
1-Year High: $10,519,247,034 on 2025-02-20
1-Year Low: $1,172,444,992 on 2025-07-25
Top Sarepta Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$SPY $SPX $QQQ NFA SOLID SAFE BOUNCE PLAY WATCHLIST 🚨 $RBLX $56-54 $PATH $8-$7 $PLTR $72-$70 $57-$54 $IONQ $15-$16 $QBTS $7-$8 $SERV $6 $GOSS $1.90-$2.00 $MPNGY $16-$17 $FCEL $6 $NTLA $9 $SRPT $14 $CMG $22-$24 $CPNG $13-$12 $ROOT $46-$42 $FISV $48-$45 $UBER $57-$58 $BABA $121-$122 https://twitter.com/i/web/status/2023150875015860630 https://twitter.com/i/web/status/2023150875015860630"
X Link @UttamMarketJ 2026-02-15T21:42Z [---] followers, [---] engagements
"@MitchellReed09 I have built a full position. Ready for the earning report $LEGN $SRPT"
X Link @n_hatami 2026-02-15T21:36Z [---] followers, [---] engagements
"The FDA completely screwed this up and $SRPT is paying for it. Dont lecture anyone about trusting the science when your process looks like bureaucratic chaos. If this is the gold standard thats pathetic"
X Link @IroquoiInvest 2026-02-15T18:12Z [---] followers, [---] engagements
"@FidelisAurelius Just say the name. $SRPT. Trashiest company and worst CEO of all time"
X Link @teslarosa 2026-02-15T06:19Z [--] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing